Trial · NCT01043185
Results by group20
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 20
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Total Number of Reflux Episodes During 24 Hours | AZD3355 30 mg | 59.4 | 95% Confidence Interval 49.1 to 71.8 | Episodes | |
| Total Number of Reflux Episodes During 24 Hours | AZD3355 90 mg | 50.7 | 95% Confidence Interval 41.8 to 61.4 | Episodes | |
| Total Number of Reflux Episodes During 24 Hours | AZD3355 120 mg | 44.3 | 95% Confidence Interval 36.9 to 53.2 | Episodes | |
| Total Number of Reflux Episodes During 24 Hours | AZD3355 240 mg | 38.0 | 95% Confidence Interval 31.4 to 46.0 | Episodes | |
| Total Number of Reflux Episodes During 24 Hours | Placebo | 80.5 | 95% Confidence Interval 67.5 to 96.1 | Episodes | |
| Number of Acid Reflux Episodes | AZD3355 30 mg | 9.6 | 95% Confidence Interval 4.9 to 18.8 | Episodes | |
| Number of Acid Reflux Episodes | AZD3355 90 mg | 8.0 | 95% Confidence Interval 4.1 to 15.8 | Episodes | |
| Number of Acid Reflux Episodes | AZD3355 120 mg | 6.2 | 95% Confidence Interval 3.2 to 12.0 | Episodes | |
| Number of Acid Reflux Episodes | AZD3355 240 mg | 6.3 | 95% Confidence Interval 3.2 to 12.4 | Episodes | |
| Number of Acid Reflux Episodes | Placebo | 14.7 | 95% Confidence Interval 7.7 to 28.0 | Episodes | |
| Number of Weakly Acidic Reflux Episodes | AZD3355 30 mg | 37.0 | 95% Confidence Interval 27.4 to 49.9 | Episodes | |
| Number of Weakly Acidic Reflux Episodes | AZD3355 90 mg | 35.4 | 95% Confidence Interval 26.2 to 47.8 | Episodes | |
| Number of Weakly Acidic Reflux Episodes | AZD3355 120 mg | 28.7 | 95% Confidence Interval 21.5 to 38.3 | Episodes | |
| Number of Weakly Acidic Reflux Episodes | AZD3355 240 mg | 28.4 | 95% Confidence Interval 21.0 to 38.3 | Episodes | |
| Number of Weakly Acidic Reflux Episodes | Placebo | 51.6 | 95% Confidence Interval 39.0 to 68.2 | Episodes | |
| Number of Weakly Alkaline Reflux Episodes | AZD3355 30 mg | 0 | Full Range 0 to 0 | Episodes | |
| Number of Weakly Alkaline Reflux Episodes | AZD3355 90 mg | 0 | Full Range 0 to 1 | Episodes | |
| Number of Weakly Alkaline Reflux Episodes | AZD3355 120 mg | 0 | Full Range 0 to 1 | Episodes | |
| Number of Weakly Alkaline Reflux Episodes | AZD3355 240 mg | 0 | Full Range 0 to 2 | Episodes | |
| Number of Weakly Alkaline Reflux Episodes | Placebo | 0 | Full Range 0 to 1 | Episodes |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01043185/results